GOLGA6L7

Across TCGA pan-cancer cohorts, GOLGA6L7 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated GOLGA6L7 data layer compared with 3 for mutation status.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher GOLGA6L7 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated GOLGA6L7 expression acts as an unfavorable survival marker, although some lineages such as READ and UCEC show a favorable association.

KIRC, UVM, and READ are the cancer types where GOLGA6L7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.487	0.743	<.001	160	view →
UVM	OS	Median	All	0.360	0.826	<.001	57	view →
READ	DFS	Quartile	III,IV	0.727	0.261	.004	50	view →
HNSC	OS	Quartile	All	0.278	0.458	.004	46	view →
COAD	DFS	Tertile	II,III,IV	0.674	0.774	.013	42	view →
LAML	DFS	Tertile	All	0.251	0.537	.007	36	view →
UCEC	DFS	Median	IV	0.868	0.503	.001	36	view →
OV	OS	Quartile	III,IV	0.725	0.851	.015	32	view →
LGG	DFS	Tertile	All	0.633	0.802	<.001	28	view →
BLCA	DFS	Tertile	II,III,IV	0.506	0.665	.003	25	view →
SKCM	OS	Median	II,III,IV	0.676	0.781	.005	14	view →
ESCA	OS	Tertile	All	1.000	0.481	.049	14	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

GOLGA6L7–KIRC (DFS)

Open the KIRC breakdown →